These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 16803492)

  • 1. High-dose rate brachytherapy in the treatment of carcinoma of uterine cervix: twenty-year experience with cobalt after-loading system.
    Mosalaei A; Mohammadianpanah M; Omidvari S; Ahmadloo N
    Int J Gynecol Cancer; 2006; 16(3):1101-5. PubMed ID: 16803492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications.
    Ferrigno R; dos Santos Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Gentil AC; Salvajoli JV
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1123-35. PubMed ID: 11483321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transperineal low-dose rate iridium-192 interstitial brachytherapy in cervical carcinoma stage IIB.
    Budrukkar AN; Shrivastava SK; Jalali R; Agarwal JP; Deshpande DD; Nehru RM; Dinshaw KA
    Strahlenther Onkol; 2001 Oct; 177(10):517-24. PubMed ID: 11680016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
    Ferrigno R; Nishimoto IN; Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1108-16. PubMed ID: 15990016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose-rate brachytherapy in uterine cervical carcinoma.
    Patel FD; Rai B; Mallick I; Sharma SC
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulsed low dose rate brachytherapy for uterine cervix carcinoma.
    Rogers CL; Freel JH; Speiser BL
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):95-100. PubMed ID: 9989519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High dose rate cobalt-60 afterloading intracavitary therapy of uterine cervical carcinomas in Srinagarind hospital - analysis of complications.
    Pesee M; Krusun S; Padoongcharoen P
    Asian Pac J Cancer Prev; 2010; 11(2):491-4. PubMed ID: 20843138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study between two different dose fractionation schedules of cobalt-60-based HDR intracavitary brachytherapy in carcinoma cervix stages IIB-IIIC1.
    Gagrani V; Kabara J; Shukla A; Rathore NK; Rajpurohit VS; Jangid PK; Manna S
    J Cancer Res Ther; 2024 Jul; 20(5):1551-1556. PubMed ID: 38261446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of the American Brachytherapy Society guidelines for the use of high-dose rate brachytherapy in the treatment of cervical carcinoma: is 45-50.4 Gy radiochemotherapy plus 31.8 Gy in six fractions high-dose rate brachytherapy tolerable?
    Shakespeare TP; Lim KH; Lee KM; Back MF; Mukherjee R; Lu JD;
    Int J Gynecol Cancer; 2006; 16(1):277-82. PubMed ID: 16445645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulsed-dose-rate intracavitary brachytherapy for cervical carcinoma: the AIIMS experience.
    Rath GK; Sharma DN; Julka PK; Subramani V; Bahl A; Haresh KP
    Am J Clin Oncol; 2010 Jun; 33(3):238-41. PubMed ID: 19841576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two fractions of high-dose-rate brachytherapy in the management of cervix cancer: clinical experience with and without chemotherapy.
    Sood BM; Gorla G; Gupta S; Garg M; Deore S; Runowicz CD; Fields AL; Goldberg GL; Anderson PS; Vikram B
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):702-6. PubMed ID: 12062615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoma of the cervix: analysis of complications after primary external beam radiation and Ir-192 HDR brachytherapy.
    Kapp KS; Stuecklschweiger GF; Kapp DS; Poschauko J; Pickel H; Hackl A
    Radiother Oncol; 1997 Feb; 42(2):143-53. PubMed ID: 9106923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
    Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
    Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and IR-192 high-dose-rate brachytherapy.
    Kapp KS; Stuecklschweiger GF; Kapp DS; Poschauko J; Pickel H; Lahousen M; Hackl A
    Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):531-40. PubMed ID: 9806511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2).
    Toita T; Kato S; Niibe Y; Ohno T; Kazumoto T; Kodaira T; Kataoka M; Shikama N; Kenjo M; Tokumaru S; Yamauchi C; Suzuki O; Sakurai H; Numasaki H; Teshima T; Oguchi M; Kagami Y; Nakano T; Hiraoka M; Mitsuhashi N
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e49-56. PubMed ID: 21470794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose-rate remote afterloading irradiation of carcinoma of the cervix in Hong Kong: unexpectedly high complication rate.
    Choi P; Teo P; Foo W; O SK; Leung SF; Tsao SY; Shiu W
    Clin Oncol (R Coll Radiol); 1992 May; 4(3):186-91. PubMed ID: 1586638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective randomized study concerning the point A dose in high-dose rate intracavitary therapy for carcinoma of the uterine cervix. The final results.
    Chatani M; Matayoshi Y; Masaki N; Teshima T; Inoue T
    Strahlenther Onkol; 1994 Nov; 170(11):636-42. PubMed ID: 7974179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended-field radiotherapy and high-dose-rate brachytherapy in carcinoma of the uterine cervix: clinical experience with and without concomitant chemotherapy.
    Sood BM; Gorla GR; Garg M; Anderson PS; Fields AL; Runowicz CD; Goldberg GL; Vikram B
    Cancer; 2003 Apr; 97(7):1781-8. PubMed ID: 12655536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound-assisted endocavitary HDR-Ir(192) brachytherapy for unresectable locally advanced uterine cervix carcinoma: retrospective analysis focusing the efficacy and tolerability.
    Koukourakis GV; Miliadou A; Tsalafoutas I; Gkeli MG; Sotiropoulou-Lontou A
    Clin Transl Oncol; 2013 Feb; 15(2):154-9. PubMed ID: 22855184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.